Emerging Orthobunyaviruses Associated with CNS Disease
Overview
Tropical Medicine
Affiliations
The Orthobunyavirus genus comprises a wide range of arthropod-borne viruses which are prevalent worldwide and commonly associated with central nervous system (CNS) disease in humans and other vertebrates. Several orthobunyaviruses have recently emerged and increasingly more will likely do so in the future. Despite this large number, an overview of these viruses is currently lacking, making it challenging to determine importance from a One Health perspective. Causality is a key feature of determining importance, yet classical tools are unfit to evaluate the causality of orthobunyaviral CNS disease. Therefore, we aimed to provide an overview of orthobunyaviral CNS disease in vertebrates and objectify the causality strength of each virus. In total, we identified 27 orthobunyaviruses described in literature to be associated with CNS disease. Ten were associated with disease in multiple host species of which seven included humans. Seven viruses were associated with both congenital and postnatal CNS disease. CNS disease-associated orthobunyaviruses were spread across all known Orthobunyavirus serogroups by phylogenetic analyses. Taken together, these results indicate that orthobunyaviruses may have a common tendency to infect the CNS of vertebrates. Next, we developed six tailor-made causality indicators and evaluated the causality strength of each of the identified orthobunyaviruses. Nine viruses had a 'strong' causality score and were deemed causal. Eight had a 'moderate' and ten a 'weak' causality score. Notably, there was a lack of case-control studies, which was only available for one virus. We, therefore, stress the importance of proper case-control studies as a fundamental aspect of proving causality. This comprehensible overview can be used to identify orthobunyaviruses which may be considered causal, reveal research gaps for viruses with moderate to low causality scores, and provide a framework to evaluate the causality of orthobunyaviruses that may newly emerge in the future.
The Role of Orthobunyavirus Glycoprotein Gc in the Viral Life Cycle: From Viral Entry to Egress.
Gao H, Zhao D, Li C, Deng M, Li G, Chen S Molecules. 2025; 30(3).
PMID: 39942606 PMC: 11820035. DOI: 10.3390/molecules30030503.
Square the Circle: Diversity of Viral Pathogens Causing Neuro-Infectious Diseases.
Nurmukanova V, Matsvay A, Gordukova M, Shipulin G Viruses. 2024; 16(5).
PMID: 38793668 PMC: 11126052. DOI: 10.3390/v16050787.
Armstrong P, Anderson J, Sharma R, Misencik M, Bransfield A, Vossbrinck C Am J Trop Med Hyg. 2024; 110(5):968-970.
PMID: 38531101 PMC: 11066360. DOI: 10.4269/ajtmh.23-0799.
Organotypic culture of human brain explants as a preclinical model for AI-driven antiviral studies.
Partiot E, Gorda B, Lutz W, Lebrun S, Khalfi P, Mora S EMBO Mol Med. 2024; 16(4):1004-1026.
PMID: 38472366 PMC: 11018746. DOI: 10.1038/s44321-024-00039-9.
Hartman A, Myler P J Infect Dis. 2023; 228(Suppl 6):S376-S389.
PMID: 37849397 PMC: 10582323. DOI: 10.1093/infdis/jiac338.